World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
56
Citations
10996
World Ranking
3726
National Ranking
82

Karin Loré publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Karin Loré sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 157 publications — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Karin Loré D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Karin Loré sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Karin Loré is affiliated with the Karolinska Institute in Sweden and has contributed extensively to the fields of Medicine and Immunology and Microbiology. Their research predominantly focuses on Infectious Diseases, Immunology, and Epidemiology, with additional work in Molecular Biology and Oncology.

The main topics of their work include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Immunotherapy and Immune Responses, T-cell and B-cell Immunology, Immune Cell Function and Interaction, Immunodeficiency and Autoimmune Disorders, and Immune Response and Inflammation.

Notable recent papers authored or co-authored by Karin Loré include:

  • Innate immune mechanisms of mRNA vaccines, 2022, Immunity
  • Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial, 2021, EBioMedicine
  • Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation, 2020, Journal for ImmunoTherapy of Cancer
  • Single cell transcriptomics of primate sensory neurons identifies cell types associated with chronic pain, 2021, Nature Communications
  • Immunity to SARS-CoV-2 induced by infection or vaccination, 2021, Journal of Internal Medicine

Karin Loré frequently collaborates with co-authors, including Sebastian Ols, Fredrika Hellgren, Klara Lenart, Alberto Cagigi, and Rodrigo Arcoverde Cerveira, each contributing to multiple joint publications.

Their work is often published in several recurring journals and platforms such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Immunity
  • EBioMedicine
  • Zenodo (CERN European Organization for Nuclear Research)

Best Publications

  • Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus.

    Jessica Marcandalli;Brooke Fiala;Sebastian Ols;Michela Perotti;Michela Perotti

  • HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates

    Ulrike Wille-Reece;Barbara J. Flynn;Karin Loré;Richard A. Koup

  • Innate immune mechanisms of mRNA vaccines

    Unknown

  • Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques

    Frank Liang;Gustaf Lindgren;Ang Lin;Elizabeth A. Thompson

  • Toll-Like Receptor Ligands Modulate Dendritic Cells to Augment Cytomegalovirus- and HIV-1-Specific T Cell Responses

    Karin Loré;Michael R. Betts;Jason M. Brenchley;Janaki Kuruppu

  • Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates

    Ulrike Wille-Reece;Barbara J. Flynn;Karin Loré;Richard A. Koup

  • Imatinib inhibits T-cell receptor mediated T-cell proliferation and activation in a dose-dependent manner

    Ruth Seggewiss;Karin Loré;Elisabeth Greiner;Magnus K. Magnusson

  • Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells.

    Karin Loré;Anna Smed-Sörensen;Jayanand Vasudevan;John R. Mascola

  • Differential Susceptibility to Human Immunodeficiency Virus Type 1 Infection of Myeloid and Plasmacytoid Dendritic Cells

    Anna Smed-Sörensen;Karin Loré;Jayanand Vasudevan;Mark K. Louder

  • Neutrophils acquire the capacity for antigen presentation to memory CD4+ T cells in vitro and ex vivo.

    Maria Vono;Ang Lin;Anna Norrby-Teglund;Richard A. Koup

  • Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates

    Luca Cassetta;Espen Sønderaal Bækkevold;Sven Brandau;Anna Bujko

  • Accumulation of DC-SIGN+CD40+ dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection.

    Karin Loré;Anders Sönnerborg;Christina Broström;Li-Ean Goh

  • Adjuvant-dependent Innate and Adaptive Immune Signatures of Risk of SIVmac251 Acquisition

    Monica Vaccari;Shari N Gordon;Slim Fourati;Luca Schifanella;Luca Schifanella

  • Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial.

    Peter Bergman;Peter Bergman;Ola Blennow;Ola Blennow;Lotta Hansson;Lotta Hansson;Stephan Mielke;Stephan Mielke

  • Clonal tracking of rhesus macaque hematopoiesis highlights a distinct lineage origin for natural killer cells.

    Chuanfeng Wu;Brian Li;Rong Lu;Samson J. Koelle

  • Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake.

    Frank Liang;Gustaf Lindgren;Kerrie J. Sandgren;Elizabeth A. Thompson

  • The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration.

    Michael R. Betts;David A. Price;Jason M. Brenchley;Karin Loré

  • Interleukin-8 Stimulates Human Immunodeficiency Virus Type 1 Replication and Is a Potential New Target for Antiretroviral Therapy

    Brian R. Lane;Karin Lore;Paul J. Bock;Jan Andersson

  • Infection of Specific Dendritic Cells by CCR5-Tropic Human Immunodeficiency Virus Type 1 Promotes Cell-Mediated Transmission of Virus Resistant to Broadly Neutralizing Antibodies

    Lakshmanan Ganesh;Kwanyee Leung;Karin Loré;Reuven Levin;Reuven Levin

  • Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation.

    Luca Cassetta;Kirsten Bruderek;Joanna Skrzeczynska-Moncznik;Oktawia Osiecka

  • Granulocytes: New Members of the Antigen-Presenting Cell Family.

    Ang Lin;Karin Loré

  • HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation.

    Anna Smed-Sörensen;Karin Loré;Lilian Walther-Jallow;Jan Andersson

Frequent Co-Authors

Gunilla B. Karlsson Hedestam
Gunilla B. Karlsson Hedestam Karolinska Institute
Richard A. Koup
Richard A. Koup National Institute of Allergy and Infectious Diseases
Robert A. Seder
Robert A. Seder National Institute of Allergy and Infectious Diseases
Jan Andersson
Jan Andersson Karolinska Institute
Richard T. Wyatt
Richard T. Wyatt Scripps Research Institute
John R. Mascola
John R. Mascola ModeX Therapeutics
Mario Roederer
Mario Roederer National Institute of Allergy and Infectious Diseases
Sijy O'Dell
Sijy O'Dell National Institute of Allergy and Infectious Diseases
Robert J. Wilkinson
Robert J. Wilkinson The Francis Crick Institute
Susan W. Barnett
Susan W. Barnett Bill & Melinda Gates Foundation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career prospects. Many professionals start with nursing and then specialize further. Transitioning from Certified Family Nurse Practitioner (FNP) roles to more focused areas like acute care requires dedicated pathways, such as those found in fnp to acute care np programs. These help enhance clinical skills specific to acute patient management.

Accelerated pathways are popular among those aiming to progress quickly. For example, accelerated rn to np programs offer a fast-tracked approach to becoming a Nurse Practitioner, which can complement immunology expertise in clinical research or patient care.

For people without a nursing background, starting with online rn programs for non nurses provides an accessible way into healthcare. These programs lay the foundational knowledge necessary to engage with immunological health challenges at the bedside.

Additionally, those looking to quickly enter the nursing workforce might consider 12-month accelerated nursing programs, which are designed for highly motivated students seeking a swift route to licensure and practice. This can be an excellent stepping stone toward advanced immunology-related roles.

Best Scientists Citing Karin Loré

Trending Scientists

Recently Published Articles